AI assistant
AML3D LIMITED — Capital/Financing Update 2024
Apr 10, 2024
64357_rns_2024-04-10_a23f60f4-406e-46ca-832b-bb697fdace81.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
ASX Release 11 April 2024
==> picture [52 x 47] intentionally omitted <==
NON-RENOUNCEABLE RIGHTS ISSUE
Despatch of Offer Letter to Eligible Shareholders
AML3D Limited (ASX:AL3) (" AML3D " or " the Company ") is pleased to announce the despatch of the letter to eligible shareholders attached as an Annexure to this announcement, in relation to the Non-renounceable Rights Issue (Offer) as announced on 3 April 2024.
The Company also advises that the Offer and the Offer website below are now open: www.computersharecas.com.au/AL3Offer
This announcement has been authorised by the Board of AML3D Limited.
Sean Ebert Hamish McEwin Managing Director Chief Financial Officer AML3D Limited AML3D Limited T: +61 8 8258 2658 T: +61 8 8258 2658 E: [email protected] E: [email protected]
About AML3D Limited
AML3D Limited, a publicly listed technology company founded in 2014, is disrupting metal part supply chains using the Company’s patented Wire Additive Manufacturing (WAM®) process. WAM® combines state-of-the-art welding science, robotics automation, materials engineering and proprietary software to lead metal additive manufacturing globally. AML3D is the OEM of the ARCEMY® industrial metal 3D printing systems. ARCEMY® uses WAM® to provide advanced, automated, on-demand, point-of-need 3D manufacturing solutions that are more efficient, cost-effective and have better ESG outcomes compared to traditional casting, forging and billet machining processes. ARCEMY® is IIoT and Industry 4.0 enabled to allow manufacturers across Aerospace, Defence, Maritime, Manufacturing, Mining and Oil & Gas to become globally competitive. AML3D also provides metal 3D printing design engineering services, software licencing, technical support, consumable sales and contract manufacturing services.
Page Page | 1
AML3D Limited (ASX:AL3) ACN 602 857 983 | Australian Patent 2019251514
11 April 2024
LETTER TO ELIGIBLE SHAREHOLDERS - NON-RENOUNCEABLE RIGHTS ISSUE
Dear Shareholder,
The Company has reached a pivotal point in its journey and wishes to invite you to play a part in its continued growth and future success.
With these objectives in mind, the Board has determined to undertake a pro rata non-renounceable rights issue to raise up to $3.9 million ( Offer ). This new capital will be used for two primary purposes:
-
Establish a US presence: The Ohio based manufacturing facility will house AML3D’s US headquarters and operating facility. The US facility will be led by the recently appointed President of US Operations, Mr Pete Goumas and will build AML3D’s ARCEMY[®] advanced manufacturing systems; fulfill contract manufacturing, alloy testing and prototyping contracts and house AML3D’s US sales and operating functions. Following successful completion of the capital raise AML3D will be positioned to rapidly scale up its US employee base to meet the strong and growing demand in the US for advanced manufacturing technology solutions.
-
Invest in its software and technology: AML3D will also invest in its software and technology to maintain the Company’s competitive advantage and increase the applications of its Wire-Arc Additive Manufacturing solutions, particularly in support of the US Defence sector. This investment will include expanding AML3D’s software development expertise and capabilities to build out new features that will enhance AML3D’s ARCEMY[® ] platform in both build size and speed and maintain its position as a market leading advance additive manufacturing solution.
About the Offer
Under the Entitlement Offer, Eligible Shareholders who are on the Company's share register at 7:00p.m. (Adelaide time) on 8 April 2024 ( Record Date ) will be entitled to subscribe for one (1) New Share for every three (3) Shares ( Entitlement ), at an Issue Price of $0.05 per New Share to raise up to approximately $3.9 million, on the terms set out in this Offer Booklet.
Eligible Shareholders who subscribe for their full Entitlement may also apply for New Shares in excess of their Entitlement ( Shortfall Shares ) under the Shortfall Offer, details of which are set out in the Offer Booklet.
The Entitlement Offer is not underwritten.
The Issue Price equates to a discount of approximately 28.57% based on the Share price of $0.070 at the close of trading on 25 March 2024, a discount of approximately 29.38% to the 5-day volume weighted average price (in which trades were recorded) up to and including 25 March 2024 of $0.0708 and a discount of approximately 23.1% to the theoretical ex-rights price of $0.065.
Entitlements are non-renounceable and will not be tradeable on ASX or otherwise transferrable. Eligible Shareholders who do not take up their Entitlement will not receive any value in respect of those Entitlements.
This letter is to notify you that the Entitlement Offer is now open and to provide you with instructions on how to obtain a copy of the Offer Booklet and your personalised Entitlement and Acceptance Form.
Page
Page | 1
AML3D Limited (ASX:AL3) ACN 602 857 983 | Australian Patent 2019251514
How to obtain a copy of the Offer Booklet and your personalised Entitlement and Acceptance Form:
1. ONLINE : To accept the offer and subscribe for New Shares under the Entitlement Offer, Eligible Shareholders can view a copy of the Offer Booklet and their personalised Entitlement and Acceptance Form online at www.computersharecas.com.au/AL3Offer . To access the website you will need your SRN or HIN, which is displayed at the top of this letter.
2. PAPER : You can request a paper copy of your Offer Booklet and their personalised Entitlement and Acceptance Form by contacting the Information Line which can be reached either by phone on 1300 362 398 (+61 2 8355 1004 outside Australia).
Indicative Timetable
| Activity | Date |
|---|---|
| Announcement of Rights Issue | Wednesday, 3 April 2024 |
| ‘Ex’ Date | Friday, 5 April 2024 |
| Record Date for Rights Issue | Monday, 8 April 2024 |
| Despatch of Offer Booklet and personalised entitlement and | |
| acceptance forms to persons entitled and announcement and | Thursday, 11 April 2024 |
| Rights Issue opens | |
| Closing Date of Rights Issue | Thursday, 9 May 2024 |
| New Shares quoted on deferred settlement basis | Friday, 10 May 2024 |
| Announcement of results of Rights Issue and shortfall | Before noon on Thursday, |
| (if any) and issue of new Shares under the Rights Issue | 16 May 2024 |
| Quotation of new Shares issued under the Rights Issue on ASX | Friday, 17 May 2024 |
| Despatch date for issuer sponsored holding statements and | |
| CHESS notices in relation to the new Shares issued under the | Friday, 24 May 2024 |
| Rights Issue |
The above dates are indicative only and may be subject to change.
Director participation
The Directors of the Company who are also Shareholders will be entitled to participate in the Entitlement Offer up to the Entitlement on the same terms as other Eligible Shareholders. Executive Director, Mr Andy Sales has confirmed his intention to take up part of his entitlement to the value of $50,000.
Low-doc offer
Full details and conditions of the Offer are set out in the Offer Booklet lodged with ASX today and available on the Company’s website. You should read this in its entirety and seek professional financial advice should you have any questions. On behalf of the Board, I look forward to your continued support and updating you on the Company’s progress.
Further Information
If you have any queries concerning your Entitlement, please contact the Information Line which can be reached either by phone on 1300 362 398 (+612 8355 1004 outside Australia) or through a live online chat facility by scanning the QR Code or going to chat3.shareholdersfirst.com.au The Information Line will be open 9:00am to 5:00pm (AEST), Monday through Friday (excluding public holidays) during the offer period.
Conclusion
As a Board, we appreciate the support of our existing Shareholders and we have been mindful of providing existing Shareholders with the opportunity to increase their investment in the Company. This Entitlement Offer represents an opportunity for Shareholders to participate directly in an exciting new growth phase for the Company, and, on behalf of my fellow Directors, we thank you for your continued support.
Noel Cornish
Chairman AML3D Limited
Page
Page | 2
AML3D Limited (ASX:AL3) ACN 602 857 983 | Australian Patent 2019251514